S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

HEPA Hepion Pharmaceuticals Inc

0.1745

-0.0121 (-6.48%)

Jan 31 2025 - Closed

Delayed by 15 minutes

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

Hepion Pharmaceuticals (NASDAQ:HEPA)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Hepion Pharmaceuticals Charts.

Hepion Pharmaceuticals (NASDAQ:HEPA)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Hepion Pharmaceuticals Charts.

Hepion Pharmaceuticals Inc News

Hepion Pharmaceuticals Announces $9.0 Million Public Offering
Wednesday 22 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Monday 13 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 11 December 2024 (2 months ago) • Edgar (US Regulatory)

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
Wednesday 11 December 2024 (2 months ago) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 5 December 2024 (2 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 2 December 2024 (2 months ago) • Edgar (US Regulatory)

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
Monday 2 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 425 - Prospectuses and communications, business combinations
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger
Monday 11 November 2024 (3 months ago) • GlobeNewswire Inc.

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger
Wednesday 4 September 2024 (5 months ago) • GlobeNewswire Inc.

Form 425 - Prospectuses and communications, business combinations
Wednesday 7 August 2024 (6 months ago) • Edgar (US Regulatory)

More Hepion Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions